Demonstration of the Medical Interest of the VisioCyt® Artificial Intelligence Test

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
European, multicenter clinical trial with VisioCyt®, an in vitro diagnostic medical device. VisioCyt® is an innovative solution for the early diagnosis of bladder cancer.
Epistemonikos ID: 8f8d10a0e8392b65c080f413436cb8a8cdebca98
First added on: May 09, 2024